Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Schizophrenia

Free Subscription Articles published in J Clin Psychopharmacol Retrieve available abstracts of 144 articles: HTML format

Single Articles

July 2021
1. 
   Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia: Erratum.
   J Clin Psychopharmacol. 2021;41:507.
   PubMed    
   
   
   June 2021
2. KOREKI A, Mori H, Nozaki S, Koizumi T, et al
   Risk of Nonalcoholic Fatty Liver Disease in Patients With Schizophrenia Treated With Antipsychotic Drugs: A Cross-sectional Study.
   J Clin Psychopharmacol. 2021 Jun 4. pii: 00004714-900000000-98299.
   PubMed     Abstract available
   
   
   April 2021
3. GUIMARAES TM, Guimaraes MRC, Oliveira IAF, Leoni RF, et al
   Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia: A Randomized Controlled Crossover Trial.
   J Clin Psychopharmacol. 2021 Apr 14. pii: 00004714-900000000-98311.
   PubMed     Abstract available
   
   
   
4. LINDENMAYER JP, Rizvi S
   Augmentation With Pimavanserin in Treatment Refractory Schizophrenia: Case Report.
   J Clin Psychopharmacol. 2021 Apr 13. pii: 00004714-900000000-98312.
   PubMed    
   
   
   March 2021
5. AN H, Fan H, Chen S, Qi S, et al
   Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With Schizophrenia.
   J Clin Psychopharmacol. 2021 Mar 31. pii: 00004714-900000000-98320.
   PubMed     Abstract available
   
   
   
6. WANG J, Hart KL, Qi W, Ardekani BA, et al
   Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia.
   J Clin Psychopharmacol. 2021 Mar 31. pii: 00004714-900000000-98319.
   PubMed     Abstract available
   
   
   
7. BUCHANAN RW, Kelly DL, Strauss GP, Gold JM, et al
   Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia.
   J Clin Psychopharmacol. 2021 Mar 30. pii: 00004714-900000000-98321.
   PubMed     Abstract available
   
   
   
8. BALDAQUI N, Anmella G, Gomez-Ramiro M, Guasp M, et al
   Thyrotoxic Psychosis Associated With Amiodarone.
   J Clin Psychopharmacol. 2021 Mar 12. pii: 00004714-900000000-98331.
   PubMed    
   
   
   
9. LECLERC LD, Demers MF, Bardell A, Bilodeau I, et al
   A Chart Audit Study of Clozapine Utilization in Early Psychosis.
   J Clin Psychopharmacol. 2021 Mar 12. pii: 00004714-900000000-98327.
   PubMed     Abstract available
   
   
   
10. IWATA Y, Aruga Y, Ohtsuki M, Inoue M, et al
    Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia: Case Presentation and Literature Review.
    J Clin Psychopharmacol. 2021;41:210-212.
    PubMed    
    
    
    February 2021
11. BENGTSSON J, Olsson E, Igelstrom H, Persson J, et al
    Ambulatory Heart Rate Variability in Schizophrenia or Depression: Impact of Anticholinergic Burden and Other Factors.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98342.
    PubMed     Abstract available
    
    
    
12. ANDARI E, Massa NM, Fargotstein MD, Taylor NB, et al
    Effects of Oxytocin on Emotion Recognition in Schizophrenia: A Randomized Double-Blind Pilot Study.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98352.
    PubMed     Abstract available
    
    
    
13. MIYAUCHI T
    Long-Term Improvement of Aggression in a Patient With Schizophrenia Using Allopurinol as an Adjuvant: A Case Report.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98348.
    PubMed    
    
    
    
14. DE BEAUREPAIRE R
    Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia: Prevalence, Antipsychotic Specificities, and Changes Over Time.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98347.
    PubMed     Abstract available
    
    
    
15. LEISING J, Barr AM, Procyshyn RM, Ainsworth NJ, et al
    High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98344.
    PubMed     Abstract available
    
    
    
16. KELLY DL, Kane MA, Fraser CM, Sayer MA, et al
    Prebiotic Treatment Increases Serum Butyrate in People With Schizophrenia: Results of an Open-Label Inpatient Pilot Clinical Trial.
    J Clin Psychopharmacol. 2021 Feb 11. pii: 00004714-900000000-98356.
    PubMed    
    
    
    
17. BO Q, Xing X, Li T, Mao Z, et al
    Menstrual Dysfunction in Women With Schizophrenia During Risperidone Maintenance Treatment.
    J Clin Psychopharmacol. 2021 Feb 1. pii: 00004714-900000000-98361.
    PubMed     Abstract available
    
    
    January 2021
18. PRIDMORE S, Naguy A, Moodliar-Rensburg S, Alamiri B, et al
    Advantageous Add-on Duloxetine to Aripiprazole-Responsive Early-Onset Schizophrenia.
    J Clin Psychopharmacol. 2021;41:91-92.
    PubMed    
    
    
    
19. SUBEESH V, Maheswari E, Singh H, Neha R, et al
    Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode Psychosis.
    J Clin Psychopharmacol. 2021;41:58-61.
    PubMed     Abstract available
    
    
    
20. MAGUIRE A, Mooney C, Flynn G, Ferguson Y, et al
    No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.
    J Clin Psychopharmacol. 2021;41:53-57.
    PubMed     Abstract available
    
    
    
21. VERMA M, Grover S, Chakrabarti S
    Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics.
    J Clin Psychopharmacol. 2021;41:36-44.
    PubMed     Abstract available
    
    
    
22. HOSSEININASAB M, Zarghami M, Mazhari S, Salehifar E, et al
    Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Clin Psychopharmacol. 2021;41:25-30.
    PubMed     Abstract available
    
    
    
23. BLACKMAN G, Lisshammar JEL, Zafar R, Pollak TA, et al
    Clozapine Response in Schizophrenia and Hematological Changes.
    J Clin Psychopharmacol. 2021;41:19-24.
    PubMed     Abstract available
    
    
    November 2020
24. LE MOIGNE A, Fava M, Csernansky J, Newcomer JW, et al
    Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.
    J Clin Psychopharmacol. 2020 Nov 16. doi: 10.1097/JCP.0000000000001319.
    PubMed    
    
    
    
25. RUIZ DE PELLON SANTAMARIA A
    Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.
    J Clin Psychopharmacol. 2020;40:641-642.
    PubMed    
    
    
    
26. DROSOS P, Bronnick K, Joa I, Johannessen JO, et al
    One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study.
    J Clin Psychopharmacol. 2020;40:534-540.
    PubMed     Abstract available
    
    
    October 2020
27. NGUYEN AS, Grossman-Kahn R, Wichser L
    Anticipatory Clozapine Dosing After Discharge From Inpatient Treatment for the Patient With Comorbid Schizophrenia and Tobacco Use.
    J Clin Psychopharmacol. 2020 Oct 14. doi: 10.1097/JCP.0000000000001294.
    PubMed    
    
    
    September 2020
28. MEYER RE
    Thoughts About Schizophrenia 66 Years After Chlorpromazine.
    J Clin Psychopharmacol. 2020;40:436-438.
    PubMed    
    
    
    
29. CHEN B, Wang C, Xu X, Lyu H, et al
    Risk of Prolonged Corrected QT Interval With Amisulpride Therapy for Renal Function Management in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2020;40:482-486.
    PubMed     Abstract available
    
    
    August 2020
30. VAHDANI B, Armani Kian A, Esmaeilzadeh A, Zenoozian S, et al
    Adjunctive Raloxifene and Isradipine Improve Cognitive Functioning in Patients With Schizophrenia: A Pilot Study.
    J Clin Psychopharmacol. 2020 Aug 11. doi: 10.1097/JCP.0000000000001274.
    PubMed     Abstract available
    
    
    
31. BUCHANAN RW, Weiner E, Kelly DL, Gold JM, et al
    Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia.
    J Clin Psychopharmacol. 2020 Aug 11. doi: 10.1097/JCP.0000000000001253.
    PubMed     Abstract available
    
    
    July 2020
32. OHI K, Muto Y, Sugiyama S, Shioiri T, et al
    Safety and Efficacy in Randomized Controlled Trials of Second-Generation Antipsychotics Versus Placebo for Cognitive Impairments in Schizophrenia: A Meta-Analysis.
    J Clin Psychopharmacol. 2020 Jul 24. doi: 10.1097/JCP.0000000000001232.
    PubMed    
    
    
    
33. KWON JS, Lee J, Kim E, Kim SW, et al
    A Prospective Study for Prediction of Psychotic Relapse Using the Korean Early Signs Scale in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2020 Jul 21. doi: 10.1097/JCP.0000000000001263.
    PubMed     Abstract available
    
    
    
34. MOGHIMI SARANI E, Memari E, Anushiravani A, Mowla A, et al
    Is Sitagliptin Effective for Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients? A Double-blind Placebo-controlled Clinical Trial.
    J Clin Psychopharmacol. 2020 Jul 21. doi: 10.1097/JCP.0000000000001259.
    PubMed     Abstract available
    
    
    
35. DONDE C, Polosan M, Guzun R
    Pitolisant for Treating Narcolepsy Comorbid With Schizophrenia.
    J Clin Psychopharmacol. 2020 Jul 15. doi: 10.1097/JCP.0000000000001243.
    PubMed    
    
    
    
36. BRUNO A, Zoccali RA, Troili GM, Scala L, et al
    Vortioxetine on Cognition in Schizophrenia: A Pilot Study.
    J Clin Psychopharmacol. 2020;40:381-385.
    PubMed     Abstract available
    
    
    
37. ROJNIC KUZMAN M, Makaric P, Bosnjak Kuharic D, Kekin I, et al
    General Functioning in Patients With First-Episode Psychosis After the First 18 Months of Treatment.
    J Clin Psychopharmacol. 2020;40:366-372.
    PubMed     Abstract available
    
    
    
38. LINDENMAYER JP, Glick ID, Talreja H, Underriner M, et al
    Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia.
    J Clin Psychopharmacol. 2020;40:346-349.
    PubMed     Abstract available
    
    
    
39. ZHENG W, Xiang YQ, Cai DB, Yang XH, et al
    Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2020;40:386-390.
    PubMed     Abstract available
    
    
    
40. CAROFF SN, Leong SH, Roberts CB, Berkowitz RM, et al
    Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia.
    J Clin Psychopharmacol. 2020;40:373-380.
    PubMed     Abstract available
    
    
    May 2020
41. YESILKAYA UH, Balcioglu YH
    Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism.
    J Clin Psychopharmacol. 2020 May 19. doi: 10.1097/JCP.0000000000001214.
    PubMed    
    
    
    
42. BIRNBAUM R, Weinberger DR
    Special Article: Translational Science Update. Pharmacological Implications of Emerging Schizophrenia Genetics: Can the Bridge From 'Genomics' to 'Therapeutics' be Defined and Traversed?
    J Clin Psychopharmacol. 2020 May 18. doi: 10.1097/JCP.0000000000001215.
    PubMed     Abstract available
    
    
    
43. FRIENDSHUH CR, Pocivavsek A, Demyonovich H, Rodriguez KM, et al
    The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G.
    J Clin Psychopharmacol. 2020;40:317-319.
    PubMed    
    
    
    
44. KUZIN M, Bochon B, Vagiaris E, Dammann G, et al
    Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2020;40:306-308.
    PubMed    
    
    
    
45. MELTZER HY, Share DB, Jayathilake K, Salomon RM, et al
    Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2020;40:240-249.
    PubMed     Abstract available
    
    
    March 2020
46. GROVER S, Verma M, Chakrabarti S
    Safety of Use of Clozapine in Patients With Schizophrenia With Comorbid Diabetes Mellitus.
    J Clin Psychopharmacol. 2020 Mar 17. doi: 10.1097/JCP.0000000000001192.
    PubMed     Abstract available
    
    
    
47. GLICK ID, Zamora D, Davis JM, Suryadevara U, et al
    Are Patients With Schizophrenia Better Off With Lifetime Antipsychotic Medication?: Replication of a Naturalistic, Long-Term, Follow-Up Study of Antipsychotic Treatment.
    J Clin Psychopharmacol. 2020;40:145-148.
    PubMed     Abstract available
    
    
    
48. DANIEL NM, Maroney M
    Rates of Conversion From Substance-Associated Psychotic Disorder to Bipolar or Schizophrenia Spectrum Disorder in a Community-Based Teaching Hospital.
    J Clin Psychopharmacol. 2020;40:212-213.
    PubMed    
    
    
    
49. DE DONATIS D, Porcelli S, Serretti A, Florio V, et al
    Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient With Chronic Renal Failure: A Case Report.
    J Clin Psychopharmacol. 2020;40:200-202.
    PubMed    
    
    
    
50. CORBEIL O, Corbeil S, Giroux I, Jacques C, et al
    Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports.
    J Clin Psychopharmacol. 2020;40:191-194.
    PubMed     Abstract available
    
    
    January 2020
51. SUGAI T, Suzuki Y, Yamazaki M, Sugawara N, et al
    Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy.
    J Clin Psychopharmacol. 2020;40:14-17.
    PubMed     Abstract available
    
    
    
52. SMITH C, Gwynn N, Lindenmayer JP
    Pisa Syndrome and Aripiprazole.
    J Clin Psychopharmacol. 2020;40:99-101.
    PubMed    
    
    
    December 2019
53. SHADER RI
    In Addition to Pharmacotherapy and Psychotherapy for Psychosis, Is Anything Else Useful?
    J Clin Psychopharmacol. 2019 Dec 12. doi: 10.1097/JCP.0000000000001168.
    PubMed    
    
    
    
54. HIRAPARA K, Munir A, Aggarwal R
    Hypothermia Associated With Paliperidone Depot Injection in Schizophrenia Patient: A Case Report.
    J Clin Psychopharmacol. 2019 Dec 10. doi: 10.1097/JCP.0000000000001155.
    PubMed    
    
    
    
55. DESCALCO NFF, Afonso PMM
    Can Empathy Improve Therapeutic Adherence in Schizophrenia?
    J Clin Psychopharmacol. 2019 Dec 3. doi: 10.1097/JCP.0000000000001161.
    PubMed    
    
    
    
56. CHAUHAN N, Chakrabarti S, Grover S
    Attitudes to Medication-Treatment Among Patients and Caregivers: A Longitudinal Comparison of Bipolar Disorder and Schizophrenia From India.
    J Clin Psychopharmacol. 2019 Dec 3. doi: 10.1097/JCP.0000000000001144.
    PubMed     Abstract available
    
    
    November 2019
57. WALLING DP, Banerjee A, Dawra V, Boyer S, et al
    Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia.
    J Clin Psychopharmacol. 2019 Nov 1. doi: 10.1097/JCP.0000000000001128.
    PubMed     Abstract available
    
    
    
58. VESELINOVIC T, Scharpenberg M, Heinze M, Cordes J, et al
    Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia: Results From the Randomized NeSSy Trial.
    J Clin Psychopharmacol. 2019 Nov 1. doi: 10.1097/JCP.0000000000001131.
    PubMed     Abstract available
    
    
    October 2019
59. DEVRIMCI-OZGUVEN H, Atmaca M, Baran Z, Cengisiz C, et al
    Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia: A Real-World Multicenter, Retrospective, Mirror-Image Study.
    J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001133.
    PubMed     Abstract available
    
    
    
60. SANAGAWA A, Shiraishi N, Sekiguchi F, Akechi T, et al
    Successful Use of Brexpiprazole for Parkinson's Disease Psychosis Without Adverse Effects: A Case Report.
    J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001127.
    PubMed    
    
    
    
61. KORKMAZ H, Korkmaz S
    Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.
    J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001117.
    PubMed    
    
    
    
62. YEE JY, Lee TS, Lee J
    A Longitudinal Study of Serum Brain-Derived Neurotrophic Factor Levels in First-Episode Schizophrenia.
    J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001118.
    PubMed     Abstract available
    
    
    
63. SHADER RI
    Psychosis and Psychotherapy.
    J Clin Psychopharmacol. 2019 Oct 28. doi: 10.1097/JCP.0000000000001134.
    PubMed    
    
    
    
64. SABE M, Kirschner M, Kaiser S
    Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    J Clin Psychopharmacol. 2019 Oct 28. doi: 10.1097/JCP.0000000000001124.
    PubMed     Abstract available
    
    
    
65. HASSANPOUR F, Zarghami M, Mouodi S, Moosazadeh M, et al
    Adjunctive Memantine Treatment of Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Study.
    J Clin Psychopharmacol. 2019 Oct 28. doi: 10.1097/JCP.0000000000001115.
    PubMed     Abstract available
    
    
    
66. CITROME L, Ouyang J, Shi L, Meehan SR, et al
    Effect of Brexpiprazole on Agitation and Hostility in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies.
    J Clin Psychopharmacol. 2019 Oct 23. doi: 10.1097/JCP.0000000000001113.
    PubMed     Abstract available
    
    
    September 2019
67. MIURA G, Misawa F, Kawade Y, Fujii Y, et al
    Long-Acting Injectables Versus Oral Antipsychotics: A Retrospective Bidirectional Mirror-Image Study.
    J Clin Psychopharmacol. 2019;39:441-445.
    PubMed     Abstract available
    
    
    August 2019
68. CHEN SF, Shen YC
    Long-Acting Injectable Aripiprazole for a Schizophrenic Patient Concomitant With Stimulant Use Disorder.
    J Clin Psychopharmacol. 2019 Aug 19. doi: 10.1097/JCP.0000000000001087.
    PubMed    
    
    
    
69. BAPTISTA A, Choucha W
    Dramatic and Rapid Resolution of Both Psychosis and Neuroleptic-Related Catatonia With Zolpidem in a Patient With Systemic Lupus Erythematosus.
    J Clin Psychopharmacol. 2019 Aug 19. doi: 10.1097/JCP.0000000000001088.
    PubMed    
    
    
    July 2019
70. ANDORN A, Graham J, Csernansky J, Newcomer JW, et al
    Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 Program.
    J Clin Psychopharmacol. 2019 Jul 23. doi: 10.1097/JCP.0000000000001076.
    PubMed     Abstract available
    
    
    
71. NOEL MC, Powell V, Burton L, Panda R, et al
    Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical Review.
    J Clin Psychopharmacol. 2019;39:380-385.
    PubMed     Abstract available
    
    
    
72. ENGELKE C, Cordes J, Kahl KG, Schmidt-Kraepelin C, et al
    Attitudes Toward Long-Term Medication Use-A Comparison Between Concerned Populations and a Sample From the German General Population: An Example of Real World Evidence.
    J Clin Psychopharmacol. 2019;39:357-361.
    PubMed     Abstract available
    
    
    June 2019
73. LACHANCE A, Corbeil O, Corbeil S, Chalifour G, et al
    Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence.
    J Clin Psychopharmacol. 2019 Jun 14. doi: 10.1097/JCP.0000000000001068.
    PubMed     Abstract available
    
    
    
74. DEMARTINIS N 3RD, Lopez RN, Pickering EH, Schmidt CJ, et al
    A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.
    J Clin Psychopharmacol. 2019 Jun 11. doi: 10.1097/JCP.0000000000001047.
    PubMed     Abstract available
    
    
    
75. WU CS, Chen TY, Tsai SY, Chen CC, et al
    Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine: A Nationwide Cohort Study.
    J Clin Psychopharmacol. 2019 Jun 10. doi: 10.1097/JCP.0000000000001052.
    PubMed     Abstract available
    
    
    
76. OZAWA C, Bies RR, Pillai N, Suzuki T, et al
    Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Pilot, Single-Blind Randomized Controlled Trial.
    J Clin Psychopharmacol. 2019 Jun 10. doi: 10.1097/JCP.0000000000001046.
    PubMed     Abstract available
    
    
    May 2019
77. YANG N, Li S, Liu S, Lv Y, et al
    Insulin Resistance-Related Proteins Are Overexpressed in Patients and Rats Treated With Olanzapine and Are Reverted by Pueraria in the Rat Model.
    J Clin Psychopharmacol. 2019;39:214-219.
    PubMed     Abstract available
    
    
    
78. SANTOS-CASADO M, Garcia-Avello A
    Systematic Review of Gender Bias in the Clinical Trials of New Long-Acting Antipsychotic Drugs.
    J Clin Psychopharmacol. 2019;39:264-272.
    PubMed     Abstract available
    
    
    
79. CHOCHOL MD, Kataria L, O'Rourke MC, Lamotte G, et al
    Clozapine-Associated Myoclonus and Stuttering Secondary to Smoking Cessation and Drug Interaction: A Case Report.
    J Clin Psychopharmacol. 2019;39:275-277.
    PubMed    
    
    
    April 2019
80. RICOUX O, Carton L, Menard O, Deheul S, et al
    Acute Psychosis Related to Baclofen in a Patient Treated for Binge Eating Disorder Highlights the Urgent Need to Regulate Off-label Prescriptions.
    J Clin Psychopharmacol. 2019 Apr 1. doi: 10.1097/JCP.0000000000001044.
    PubMed    
    
    
    March 2019
81. PU ZP, Li GR, Zou ZP, Tao F, et al
    A Randomized, 8-Week Study of the Effects of Extended-Release Paliperidone and Olanzapine on Heart Rate Variability in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2019 Mar 28. doi: 10.1097/JCP.0000000000001023.
    PubMed     Abstract available
    
    
    
82. BRUNO A, Pandolfo G, Crucitti M, Troili GM, et al
    Effect of Red Yeast Rice on Cognitive Functioning in Schizophrenia: Data From a Pilot Study.
    J Clin Psychopharmacol. 2019 Mar 27. doi: 10.1097/JCP.0000000000001025.
    PubMed     Abstract available
    
    
    
83. KANE JM, Correll CU, Delva N, Gopal S, et al
    Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study.
    J Clin Psychopharmacol. 2019;39:180-182.
    PubMed    
    
    
    
84. LEPPLA IE, Nucifora FC, Sedlak TW
    Extended Requirement of Granulocyte Colony-Stimulating Factor for Clozapine-Associated Neutropenia.
    J Clin Psychopharmacol. 2019;39:169-172.
    PubMed    
    
    
    
85. WAGNER X, Kluge M
    Abrupt Decrease of Clozapine Plasma Concentration After Discontinuation of Flupentixol Comedication.
    J Clin Psychopharmacol. 2019;39:168-169.
    PubMed    
    
    
    
86. DUSI N, Comacchio C, Lasalvia A
    Late-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report.
    J Clin Psychopharmacol. 2019;39:175-176.
    PubMed    
    
    
    February 2019
87. KUCUKGONCU S, Guloksuz S, Tek C
    Effects of Curcumin on Cognitive Functioning and Inflammatory State in Schizophrenia: A Double-Blind, Placebo-Controlled Pilot Trial.
    J Clin Psychopharmacol. 2019 Feb 8. doi: 10.1097/JCP.0000000000001012.
    PubMed    
    
    
    January 2019
88. IVKOVIC J, Lindsten A, George V, Eriksson H, et al
    Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia.
    J Clin Psychopharmacol. 2019;39:13-19.
    PubMed     Abstract available
    
    
    
89. SAGLAM AYKUT D
    Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.
    J Clin Psychopharmacol. 2019;39:57-62.
    PubMed     Abstract available
    
    
    December 2018
90. DIAS ALVES M, Micoulaud-Franchi JA, Simon N, Vion-Dury J, et al
    Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
    J Clin Psychopharmacol. 2018;38:555-562.
    PubMed     Abstract available
    
    
    
91. MUDRA S, Luedecke D, Grafmann M, Schulte-Markwort M, et al
    Myocarditis During Treatment With Clozapine in 2 Adolescent Cases.
    J Clin Psychopharmacol. 2018;38:639-640.
    PubMed    
    
    
    October 2018
92. SUZUKI H, Hibino H, Inoue Y, Takaya A, et al
    Treatment Continuation of 3 Second-Generation Antipsychotic Long-Acting Injections, and Oral Paliperidone in Patients With Schizophrenia for 2 Years.
    J Clin Psychopharmacol. 2018 Oct 16. doi: 10.1097/JCP.0000000000000976.
    PubMed    
    
    
    
93. TANI H, Suzuki T, Wolfgang Fleischhacker W, Tomita M, et al
    Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics: A Literature Review.
    J Clin Psychopharmacol. 2018 Oct 8. doi: 10.1097/JCP.0000000000000959.
    PubMed     Abstract available
    
    
    September 2018
94. KAKUNJE A, Prabhu A, Priya Es S, Karkal R, et al
    Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia.
    J Clin Psychopharmacol. 2018 Sep 6. doi: 10.1097/JCP.0000000000000940.
    PubMed    
    
    
    August 2018
95. DIEFENDERFER LA, Lang SE, Patel M
    Successful Treatment of Delusional Disorder With Aripiprazole Long-Acting Injection.
    J Clin Psychopharmacol. 2018;38:400-402.
    PubMed    
    
    
    
96. GONZALEZ-RODRIGUEZ A, Estrada F, Monreal JA, Palao D, et al
    A Systematic Review of Methods for the Measurement of Antipsychotic Adherence in Delusional Disorder.
    J Clin Psychopharmacol. 2018;38:412-414.
    PubMed    
    
    
    July 2018
97. HARD ML, Wehr AY, Du Y, Weiden PJ, et al
    Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia.
    J Clin Psychopharmacol. 2018 Jul 13. doi: 10.1097/JCP.0000000000000921.
    PubMed     Abstract available
    
    
    June 2018
98. KELLY DL, Powell MM, Wehring HJ, Sayer MA, et al
    Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial.
    J Clin Psychopharmacol. 2018 Jun 15. doi: 10.1097/JCP.0000000000000898.
    PubMed     Abstract available
    
    
    
99. ENGLISCH S, Jung HS, Eisenacher S, Lewien A, et al
    Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study.
    J Clin Psychopharmacol. 2018 Jun 14. doi: 10.1097/JCP.0000000000000909.
    PubMed     Abstract available
    
    
    
100. BALLON JS, Ashfaq H, Noordsy DL
     Clozapine Titration for People in Early Psychosis: A Chart Review and Treatment Guideline.
     J Clin Psychopharmacol. 2018;38:234-238.
     PubMed     Abstract available
     
     
     
101. SOLISMAA A, Kampman O, Lyytikainen LP, Seppala N, et al
     Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine.
     J Clin Psychopharmacol. 2018;38:193-199.
     PubMed     Abstract available
     
     
     
102. HELLAND A, Habib S, Ulvestad L, Spigset O, et al
     Systemic Inflammation Complicates the Interpretation of Therapeutic Drug Monitoring of Risperidone.
     J Clin Psychopharmacol. 2018;38:263-265.
     PubMed    
     
     
     April 2018
103. GAUDIANO BA, Guzman Holst C, Morena A, Reeves LE, et al
     Complex Polypharmacy in Patients With Schizophrenia-Spectrum Disorders Before a Psychiatric Hospitalization: Prescribing Patterns and Associated Clinical Features.
     J Clin Psychopharmacol. 2018 Apr 3. doi: 10.1097/JCP.0000000000000876.
     PubMed     Abstract available
     
     
     
104. BOTILLO-MARTIN C, Gonzalez-Pablos E
     Rhabdomyolysis of Multifactorial Origin in Schizophrenia: Antipsychotics, Statins, Trauma.
     J Clin Psychopharmacol. 2018 Apr 2. doi: 10.1097/JCP.0000000000000880.
     PubMed    
     
     
     
105. SAVULICH G, Mezquida G, Atkinson S, Bernardo M, et al
     A Case Study of Clozapine and Cognition: Friend or Foe?
     J Clin Psychopharmacol. 2018;38:152-153.
     PubMed    
     
     
     March 2018
106. JONES C
     alpha7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
     J Clin Psychopharmacol. 2018 Mar 2. doi: 10.1097/JCP.0000000000000859.
     PubMed     Abstract available
     
     
     February 2018
107. HAJI SEYED JAVADI A, Shafikhani AA, Zamir SM, Khanshir ZF, et al
     Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment: A Clinical Trial.
     J Clin Psychopharmacol. 2018 Feb 9. doi: 10.1097/JCP.0000000000000850.
     PubMed     Abstract available
     
     
     
108. LIU F, Xie L, Zhang B, Ruan Y, et al
     No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia.
     J Clin Psychopharmacol. 2018 Feb 8. doi: 10.1097/JCP.0000000000000841.
     PubMed     Abstract available
     
     
     
109. ZHAI D, Liu Y, Ma F, Feng Y, et al
     Effects of the First Exposure of Antipsychotics on Serum Albumin in Adolescents and Young Adults With First-Episode Schizophrenia.
     J Clin Psychopharmacol. 2018;38:103-105.
     PubMed    
     
     
     
110. SAPRA M, Lawson D, Iranmanesh A
     Fat Distribution in Schizophrenia Patients: A Pilot Study Comparing First- and Second-Generation Antipsychotics.
     J Clin Psychopharmacol. 2018;38:68-71.
     PubMed     Abstract available
     
     
     
111. ZHAO MJ, Qin B, Wang JB, Zhang YP, et al
     Efficacy and Acceptability of Cariprazine in Acute Exacerbation of Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials.
     J Clin Psychopharmacol. 2018;38:55-59.
     PubMed     Abstract available
     
     
     
112. DYKEMA LR
     Abrupt Improvement in Obsessive-Compulsive Symptoms Upon Discontinuation of Clozapine.
     J Clin Psychopharmacol. 2018;38:88-89.
     PubMed    
     
     
     December 2017
113. LIMOSIN F, Belhadi D, Comet D, Pacou M, et al
     Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.
     J Clin Psychopharmacol. 2017 Dec 11. doi: 10.1097/JCP.0000000000000827.
     PubMed     Abstract available
     
     
     
114. COLLE R, Boichot F, Bouteiller E, Elie-Lefebvre C, et al
     Restless Legs Syndrome and Schizophrenia: A Case Report.
     J Clin Psychopharmacol. 2017 Dec 6. doi: 10.1097/JCP.0000000000000832.
     PubMed    
     
     
     November 2017
115. ALY EL-GABRY DM, Abdel Aziz K, Okasha T, Azzam H, et al
     Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia: An Egyptian Study.
     J Clin Psychopharmacol. 2017 Nov 28. doi: 10.1097/JCP.0000000000000815.
     PubMed     Abstract available
     
     
     October 2017
116. SANDERS LLO, Menezes CES, Chaves Filho AJM, Viana GA, et al
     alpha-Lipoic Acid as Adjunctive Treatment for Schizophrenia: An Open-Label Trial.
     J Clin Psychopharmacol. 2017 Oct 19. doi: 10.1097/JCP.0000000000000800.
     PubMed     Abstract available
     
     
     
117. JOY G, Whiskey E, Bolstridge M, Porras-Segovia A, et al
     Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.
     J Clin Psychopharmacol. 2017 Oct 19. doi: 10.1097/JCP.0000000000000792.
     PubMed     Abstract available
     
     
     
118. FEELEY RJ, Arnaout B, Yoon G
     Effective Switch From Clozapine to Aripiprazole in Treatment-Resistant Schizophrenia and Comorbid Alcohol Use Disorder.
     J Clin Psychopharmacol. 2017 Oct 12. doi: 10.1097/JCP.0000000000000794.
     PubMed    
     
     
     
119. NAVKHARE P, Kalra G, Saddichha S
     Possible Psychosis Associated With Buprenorphine Withdrawal.
     J Clin Psychopharmacol. 2017 Oct 9. doi: 10.1097/JCP.0000000000000803.
     PubMed    
     
     
     
120. ANG MS, Abdul Rashid NA, Lam M, Rapisarda A, et al
     The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.
     J Clin Psychopharmacol. 2017 Oct 9. doi: 10.1097/JCP.0000000000000790.
     PubMed     Abstract available
     
     
     
121. BERESFORD T, Buchanan J, Thumm EB, Emrick C, et al
     Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence.
     J Clin Psychopharmacol. 2017 Oct 3. doi: 10.1097/JCP.0000000000000789.
     PubMed     Abstract available
     
     
     September 2017
122. SAJATOVIC M, Ramirez LF, Fuentes-Casiano E, Cage J, et al
     A 6-Month Prospective Trial of a Personalized Behavioral Intervention + Long-Acting Injectable Antipsychotic in Individuals With Schizophrenia at Risk of Treatment Nonadherence and Homelessness.
     J Clin Psychopharmacol. 2017 Sep 19. doi: 10.1097/JCP.0000000000000778.
     PubMed     Abstract available
     
     
     
123. HOJLUND M, Munk-Jorgensen P
     Differences in Antipsychotic Prescriptions Between Centers in Young Outpatients With Schizophrenia.
     J Clin Psychopharmacol. 2017 Sep 7. doi: 10.1097/JCP.0000000000000779.
     PubMed    
     
     
     August 2017
124. ZABALA A, Bustillo M, Querejeta I, Alonso M, et al
     A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients.
     J Clin Psychopharmacol. 2017 Aug 8. doi: 10.1097/JCP.0000000000000770.
     PubMed     Abstract available
     
     
     June 2017
125. DOYLE R, Behan C, O'Keeffe D, Masterson S, et al
     Clozapine Use in a Cohort of First-Episode Psychosis.
     J Clin Psychopharmacol. 2017 Jun 23. doi: 10.1097/JCP.0000000000000734.
     PubMed     Abstract available
     
     
     
126. SHE S, Yi W, Zhang B, Zheng Y, et al
     Worsening of Myasthenia Gravis After Administration of Antipsychotics for Treatment of Schizophrenia: A Case Report and Review of Literature.
     J Clin Psychopharmacol. 2017 Jun 20. doi: 10.1097/JCP.0000000000000741.
     PubMed    
     
     
     
127. SHAO W, Brown T, Ayub S
     Phenelzine Withdrawal-Associated Psychosis and Mania.
     J Clin Psychopharmacol. 2017 Jun 13. doi: 10.1097/JCP.0000000000000739.
     PubMed    
     
     
     
128. BRUNO A, Pandolfo G, Crucitti M, Cedro C, et al
     Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia: Data From an 8-Week, Open-Label Pilot Study.
     J Clin Psychopharmacol. 2017 Jun 6. doi: 10.1097/JCP.0000000000000730.
     PubMed     Abstract available
     
     
     
129. BARMAN R, Kumar S, Pagadala B, Detweiler MB, et al
     Cocaine Abuse, Traumatic Brain Injury, and Preexisting Brain Lesions as Risk Factors for Bupropion-Associated Psychosis.
     J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000729.
     PubMed     Abstract available
     
     
     
130. WATANABE J, Fukui N, Suzuki Y, Sugai T, et al
     Effect of GWAS-Identified Genetic Variants on Maximum QT Interval in Patients With Schizophrenia Receiving Antipsychotic Agents: A 24-Hour Holter ECG Study.
     J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000724.
     PubMed     Abstract available
     
     
     
131. KANTROWITZ JT, Nolan KA, Epstein ML, Lehrfeld N, et al
     Neurophysiological Effects of Bitopertin in Schizophrenia.
     J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000722.
     PubMed     Abstract available
     
     
     
132. BUCHANAN RW, Kelly DL, Weiner E, Gold JM, et al
     A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
     J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000720.
     PubMed     Abstract available
     
     
     
133. ZHENG W, Wang S, Ungvari GS, Ng CH, et al
     Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
     J Clin Psychopharmacol. 2017;37:341-346.
     PubMed     Abstract available
     
     
     
134. LOPEZ LV, Shaikh A, Merson J, Greenberg J, et al
     Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.
     J Clin Psychopharmacol. 2017;37:310-314.
     PubMed     Abstract available
     
     
     April 2017
135. ISMAIL Z, Peters-Strickland T, Miguelez M, Baker RA, et al
     Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores.
     J Clin Psychopharmacol. 2017 Apr 5. doi: 10.1097/JCP.0000000000000710.
     PubMed     Abstract available
     
     
     
136. KOHLER-FORSBERG O, Horsdal HT, Legge SE, MacCabe JH, et al
     Predictors of Nonhospitalization and Functional Response in Clozapine Treatment: A Nationwide, Population-Based Cohort Study.
     J Clin Psychopharmacol. 2017;37:148-154.
     PubMed     Abstract available
     
     
     March 2017
137. HARD ML, Mills RJ, Sadler BM, Turncliff RZ, et al
     Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia.
     J Clin Psychopharmacol. 2017 Mar 27. doi: 10.1097/JCP.0000000000000691.
     PubMed     Abstract available
     
     
     
138. GAHR M, Hiemke C, Connemann BJ, Schonfeldt-Lecuona C, et al
     First-Episode Psychosis Possibly due to Roxithromycin-Related Inhibition of Metabolization of Tetrahydrocannabinol.
     J Clin Psychopharmacol. 2017 Mar 21. doi: 10.1097/JCP.0000000000000707.
     PubMed    
     
     
     
139. LIN CH, Lane HY
     Clotiapine Monotherapy in a Patient With Clozapine-Resistant Schizophrenia.
     J Clin Psychopharmacol. 2017 Mar 21. doi: 10.1097/JCP.0000000000000692.
     PubMed    
     
     
     February 2017
140. LOOK ML, Boo YL, Chin PW, Hoo FK, et al
     Risperidone-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome: A Case Report.
     J Clin Psychopharmacol. 2017;37:105-106.
     PubMed    
     
     
     
141. GOTO T, Kato M, Matsumura Y, Omata N, et al
     Scopolamine Ointment for Clozapine-Associated Sialorrhea: A Case Report.
     J Clin Psychopharmacol. 2017;37:106-107.
     PubMed    
     
     
     October 2016
142. STRUBE W, Kirsch B, Padberg F, Hasan A, et al
     Transcranial Direct Current Stimulation as Monotherapy for the Treatment of Auditory Hallucinations During Pregnancy: A Case Report.
     J Clin Psychopharmacol. 2016;36:534-5.
     PubMed    
     
     
     
143. BUZINA N, Eterovic M
     Life-Threatening Lupus-Like Syndrome Associated With Clozapine.
     J Clin Psychopharmacol. 2016;36:532-4.
     PubMed    
     
     
     
144. JAKOBSEN KD, Bruhn CH, Pagsberg AK, Fink-Jensen A, et al
     Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
     J Clin Psychopharmacol. 2016;36:496-9.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: